Report Description

The global clinical trials supply & logistics market is projected to observe an impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases and cancers, upsurge demand for personalized medicines, and extensive development in technology, are fueling the market's growth. A clinical trial is a process in which several experiments, tests or studies are performed on animals and humans to analyze the results. Clinical trials are split into two types that is observational studies and interventional trials. The other factors supporting the market’s growth are, the rise in research and development activities, increasing research and development expenditure, large number of clinical trials and research studies, huge demand for vaccinations, the growing aging population, and growing inorganic growth strategies such as mergers, acquisitions, collaborations, and others by pharmaceutical and biologics industries.

Rising Emphasis on Drug Development

The growing frequency of various types of diseases such as obesity, cardiovascular, diabetes, infectious, and cancer are surging the demand for drug development, which is bolstering the growth of the market, globally. For instance, according to WHO, around 422 million people around the world have diabetes. Owing to the surge in number of people suffering from different types of diseases, the rise in demand for development of new therapies, drugs and medical devices is augmenting the growth of the market. According to the WHO, more than 80 vaccines are presently being analyzed in clinical trials, with over 180 in the pre-clinical stage. Moreover, rising fundings for drug development by government and non-government organization is a contributing factor for the growth of the market. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), PhRMA affiliates have invested considerably in drug development efforts.

Technological Advancements

The technological advancement and innovations in healthcare and medicine are driving the growth of the market. For instance, in South Korea, Asan Medical Center (AMC) has developed a new system, capable of handling clinical trial image data from group to extraction. The increasing adoption of new innovative technologies, such as cloud-enabled digital core, machine learning algorithms, radio-frequency identification (RFID), blockchain-based product tracking, and use of the internet of things to improve the quality management of clinical trial supply and logistics operations, are impelling the growth of the market. Heavy investments by several companies for the advanced technologies and logistics is propelling the growth of the market. For instance, in 2020, Almac Clinical Technologies, a section of the Almac Group, proposed Simplify, a next-generation IRT solution. It is enabled with a standard array of configurable functionality intended to speed up the study startup process.

Growing Demand for Precision Medicines

Growing prominence of personalized medicines is one of the key factors, supporting the growth of the market. For instance, in 2020, according to scope and significance of progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year. The rising demand for precision drugs is due to their efficiency to treat unique and complex diseases. New drugs and disease therapies are being developed due to rising need and use by doctors, researchers, and pharmaceutical firms, which facilitates the growth of the market.


Download Free Sample Report

Market Segmentation

The global clinical trials supply & logistics market is segmented into service, phase, therapeutic area, end user industry, and company. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labeling, & blinding, manufacturing, comparator sourcing, and others. Based on phase, the market is segmented into phase 0, phase I, phase II, and phase III. Based on therapeutic area, the market is divided into oncology, cardiovascular diseases, neurological disorders, and others. Based on end user industry, the market is divided into pharmaceutical and medical devices. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising occurrences of various types of cancer and extensive technology development in the country.

Market Players

Thermo Fisher Scientific (Patheon), Catalent, Inc., United Parcel Service (Marken), PARAXEL International Corporation, Almac Group, Piramal Pharma Solutions (Piramal Group), UDG Healthcare, plc, DHL International Limited, Packaging Coordinators Inc., and Walden Group SAS (Movianto) are some of the leading companies operating in the market.


Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Service

·         Phase

·         Therapeutic Area

·         End User Industry

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Turkey; Eqypt;

Key companies profiled

Thermo Fisher Scientific (Patheon), Catalent, Inc., United Parcel Service (Marken), PARAXEL International Corporation, Almac Group, Piramal Pharma Solutions (Piramal Group), UDG Healthcare, plc, DHL International Limited, Packaging Coordinators Inc., and Walden Group SAS (Movianto)

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global clinical trials supply & logistics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Clinical Trials Supply & Logistics Market, By Service:

    • Logistics & Distribution
    • Storage & Retention
    • Packaging
    • Labeling & Blinding
    • Manufacturing
    • Comparator Sourcing
    • Others

·         Clinical Trials Supply & Logistics Market, By Phase:

    • Phase 0
    • Phase I
    • Phase II
    • Phase III

·         Clinical Trials Supply & Logistics Market, By Therapeutic Area:

    • Oncology
    • Cardiovascular Diseases
    • Neurological Disorders
    • Others

·         Clinical Trials Supply & Logistics Market, By End User Industry:

    • Pharmaceutical
    • Medical Devices

·         Clinical Trials Supply & Logistics Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

o   South Africa

o   Saudi Arabia

o   UAE

o   Turkey

o   Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Trials Supply & Logistics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Clinical Trials Supply & Logistics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Clinical Trial Supply & Logistics Market

5.    Voice of Customer

6.    Global Clinical Trial Supply & Logistics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Service (Logistics & Distribution; Storage & Retention; Packaging, Labeling, & Blinding; Manufacturing; Comparator Sourcing; Others)

6.2.2.     By Phase (Phase 0, Phase I, Phase II, Phase III)

6.2.3.     By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Others)

6.2.4.     By End User Industry (Pharmaceutical v/s Medical Devices)

6.2.5.     By Company (2021)

6.2.6.     By Region

6.3.  Market Map

7.    North America Clinical Trial Supply & Logistics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Service

7.2.2.     By Phase

7.2.3.     By Therapeutic Area

7.2.4.     By End User Industry

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Clinical Trial Supply & Logistics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Service

7.3.1.2.2.             By Phase

7.3.1.2.3.             By Therapeutic Area

7.3.1.2.4.             By End User Industry

7.3.2.     Canada Clinical Trial Supply & Logistics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Service

7.3.2.2.2.             By Phase

7.3.2.2.3.             By Therapeutic Area

7.3.2.2.4.             By End User Industry

7.3.3.     Mexico Clinical Trial Supply & Logistics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Service

7.3.3.2.2.             By Phase

7.3.3.2.3.             By Therapeutic Area

7.3.3.2.4.             By End User Industry

8.    Europe Clinical Trial Supply & Logistics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Service

8.2.2.     By Phase

8.2.3.     By Therapeutic Area

8.2.4.     By End User Industry

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Clinical Trial Supply & Logistics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Service

8.3.1.2.2.             By Phase

8.3.1.2.3.             By Therapeutic Area

8.3.1.2.4.             By End User Industry

8.3.2.     Germany Clinical Trial Supply & Logistics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Service

8.3.2.2.2.             By Phase

8.3.2.2.3.             By Therapeutic Area

8.3.2.2.4.             By End User Industry

8.3.3.     United Kingdom Clinical Trial Supply & Logistics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Service

8.3.3.2.2.             By Phase

8.3.3.2.3.             By Therapeutic Area

8.3.3.2.4.             By End User Industry

8.3.4.     Italy Clinical Trial Supply & Logistics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Service

8.3.4.2.2.             By Phase

8.3.4.2.3.             By Therapeutic Area

8.3.4.2.4.             By End User Industry

8.3.5.     Spain Clinical Trial Supply & Logistics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Service

8.3.5.2.2.             By Phase

8.3.5.2.3.             By Therapeutic Area

8.3.5.2.4.             By End User Industry

9.    Asia-Pacific Clinical Trial Supply & Logistics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Service

9.2.2.     By Phase

9.2.3.     By Therapeutic Area

9.2.4.     By End User Industry

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Clinical Trial Supply & Logistics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Service

9.3.1.2.2.             By Phase

9.3.1.2.3.             By Therapeutic Area

9.3.1.2.4.             By End User Industry

9.3.2.     India Clinical Trial Supply & Logistics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Service

9.3.2.2.2.             By Phase

9.3.2.2.3.             By Therapeutic Area

9.3.2.2.4.             By End User Industry

9.3.3.     Japan Clinical Trial Supply & Logistics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Service

9.3.3.2.2.             By Phase

9.3.3.2.3.             By Therapeutic Area

9.3.3.2.4.             By End User Industry

9.3.4.     South Korea Clinical Trial Supply & Logistics Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Service

9.3.4.2.2.             By Phase

9.3.4.2.3.             By Therapeutic Area

9.3.4.2.4.             By End User Industry

9.3.5.     Australia Clinical Trial Supply & Logistics Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Service

9.3.5.2.2.             By Phase

9.3.5.2.3.             By Therapeutic Area

9.3.5.2.4.             By End User Industry

10.  South America Clinical Trial Supply & Logistics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Service

10.2.2.  By Phase

10.2.3.  By Therapeutic Area

10.2.4.  By End User Industry

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Clinical Trial Supply & Logistics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Service

10.3.1.2.2.           By Phase

10.3.1.2.3.           By Therapeutic Area

10.3.1.2.4.           By End User Industry

10.3.2.  Argentina Clinical Trial Supply & Logistics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Service

10.3.2.2.2.           By Phase

10.3.2.2.3.           By Therapeutic Area

10.3.2.2.4.           By End User Industry

10.3.3.  Colombia Clinical Trial Supply & Logistics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Service

10.3.3.2.2.           By Phase

10.3.3.2.3.           By Therapeutic Area

10.3.3.2.4.           By End User Industry

11.  Middle East and Africa Clinical Trial Supply & Logistics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Service

11.2.2.  By Phase

11.2.3.  By Therapeutic Area

11.2.4.  By End User Industry

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Clinical Trial Supply & Logistics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Service

11.3.1.2.2.           By Phase

11.3.1.2.3.           By Therapeutic Area

11.3.1.2.4.           By End User Industry

11.3.2.  Saudi Arabia Clinical Trial Supply & Logistics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Service

11.3.2.2.2.           By Phase

11.3.2.2.3.           By Therapeutic Area

11.3.2.2.4.           By End User Industry

11.3.3.  UAE Clinical Trial Supply & Logistics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Service

11.3.3.2.2.           By Phase

11.3.3.2.3.           By Therapeutic Area

11.3.3.2.4.           By End User Industry

11.3.4.  Turkey Clinical Trial Supply & Logistics Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Service

11.3.4.2.2.           By Phase

11.3.4.2.3.           By Therapeutic Area

11.3.4.2.4.           By End User Industry

11.3.5.  Egypt Clinical Trial Supply & Logistics Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Service

11.3.5.2.2.           By Phase

11.3.5.2.3.           By Therapeutic Area

11.3.5.2.4.           By End User Industry

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Thermo Fisher Scientific (Patheon)

14.2.              Catalent, Inc.

14.3.              United Parcel Service (Marken)

14.4.              PARAXEL International Corporation

14.5.              Almac Group

14.6.              Piramal Pharma Solutions (Piramal Group)

14.7.              UDG Healthcare, plc

14.8.              DHL International Limited

14.9.              Packaging Coordinators Inc.

14.10.            Walden Group SAS (Movianto)

15.              Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Growing occurrences of life-related diseases, technological advancements, and extensive research and development are driving the demand for the global clinical trials supply & logistics market.

down-arrow

Thermo Fisher Scientific (Patheon), Catalent, Inc., United Parcel Service (Marken), PARAXEL International Corporation, Almac Group, Piramal Pharma Solutions (Piramal Group), UDG Healthcare, plc, DHL International Limited, Packaging Coordinators Inc., and Walden Group SAS (Movianto) are the key players operating in the global clinical trials supply & logistics market.

down-arrow

The complex regulations in the clinical trial process from application to approval of new drugs, lack of necessary expertise to proliferate and high costs in managing patients, and equipments may likely hamper the growth of the global clinical trials supply & logistics market.

down-arrow

The global clinical trials supply & logistics market is studied from 2017 to 2027.

profile

Sakshi Bajaal

Business Consultant
Press Release

Clinical Trials Supply & Logistics Market to be dominated by Rising Life-Related diseases through 2027

Sep, 2022

Growing prevalence of cancer and rise in R&D activities to drive the clinical trials supply & logistics market in the forecast period, 2023-2027.